Systemic Immunity Is Required for Effective Cancer Immunotherapy. [electronic resource]
Producer: 20170529Description: 487-502.e15 p. digitalISSN:- 1097-4172
- Animals
- B7-H1 Antigen -- antagonists & inhibitors
- Bone Marrow -- immunology
- Cell Proliferation
- Disease Models, Animal
- Female
- Humans
- Immune Tolerance
- Immunotherapy
- Killer Cells, Natural -- immunology
- Lymphocyte Activation
- Lymphoid Tissue -- immunology
- Male
- Melanoma -- immunology
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Neoplasms -- immunology
- T-Lymphocyte Subsets -- immunology
- Triple Negative Breast Neoplasms -- immunology
- Tumor Microenvironment
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.